Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A04492 | Pages: NA | Charts: NA | Tables: NA |
A stent is a wired mesh tube that aids in keeping coronary arteries open and reduce the risk of a heart attack due to fat deposits in the arteries. They are made of metals, polymers, and natural bioabsorbable materials. They enhance various surgical procedures such as angioplasty or percutaneous coronary intervention (PCI). Moreover, they regulate the blood supply to the heart and are mostly made up of stainless steel. They are implanted in the esophagus to enable the passage of food and beverages in patients suffering from esophageal cancer. In addition, they are inserted in the ureter to prevent obstruction of urine flow from kidney, in the gall bladder to allow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract.
The factors such as increase in usage of stents in minimally invasive surgical procedures and surge in geriatric population in Romania prone to cardiovascular diseases and other chronic ailments fuel the growth of the Romania stents market. For instance, according to European Geriatric Medicine Society, total population of Romania was 21,666,350 in 2015. The percentage of the population aged above 85 years was 1.3% in 2011, and above 65 years was 17% in 2016. Furthermore, , according to Eurostat series, the old age dependency ratio in Romania increased from 21.5 in 2007 to 26.7 in 2017. Moreover, active participation of Romania in initiative taken toward usage of stents boosts the market growth. For instance, Romania is a member of Stent for Life Initiative that ensures the availability of lifesaving indication of primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction patients, which fuels the growth of the Romania stents market. Moreover, companies have shifted their focus on developing technologically advanced stents with the aim of serving a wider audience, thereby propelling the market growth. The coronary stents market trends such as incorporation of micro-sized stents and use of minimally invasive procedures are expected to serve as lucrative opportunities during the forecast period. Furthermore, rise in use of bioresorbable stent, increase in adoption of bifurcated stents, and upsurge in adoption of co-polymers as raw materials are anticipated to provide lucrative opportunities for the market growth across Romania.
However, high cost of treatment associated with stent implants and stringent approval process, as these are highly specialized devices are expected to hinder the market growth.
The Romania stents market is segmented into type and material. Depending on type, the Romania stents market is categorized into coronary stents, peripheral stents and stent-related implants. By material, it is divided into metallic biomaterials, polymers biomaterials and natural biomaterials.
Major players operating in the Romania stents market include Abbott Laboratories, B. Braun Melsungen Ag, Biotronik Se & Co. Kg, Boston Scientific Corporation, C. R. Bard, Inc., Medtronic Plc, Stentys S.A., Terumo Corporation, Microport Scientific Corporation, and Elixir Medical Corporation.
Key Market Segments
Key Market Players